Found 0 matching trials
A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients PHASE3 The purpose of this study is to determine if two dose levels of indinavir c...
Show More Location
1917 Research Clinic
Learn More & Join Trial
Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study PHASE3 The purpose of this study is to evaluate the change in brachial artery reac...
Show More Location
University of California
Learn More & Join Trial
HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children PHASE3 HIV and malaria are major causes of morbidity and mortality in Sub-Saharan ...
Show More Location
IDRC - Tororo Research Clinic
Learn More & Join Trial
Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune® N/A Collecting data on maintaining anti-retroviral activity (quantitative HIV R...
Show More Location
Multiple Locations
Learn More & Join Trial
Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone PHASE3 The purpose of this study is to determine the proportion of subjects with H...
Show More Location
Southwest Center For Hiv/Aids
Learn More & Join Trial
TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients PHASE2 The purpose of this study is to determine the pharmacokinetics (how the bod...
Show More Location
Multiple Locations
Learn More & Join Trial
A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults PHASE2 This is a phase 2b, randomized, multicenter, parallel group, partially blin...
Show More Location
GSK Investigational Site
Learn More & Join Trial
QDISS Stud: QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-Patient PHASE2 Raltegravir (RAL) is a very effective antiretroviral drug with a favorable ...
Show More Learn More & Join Trial
A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients PHASE2 Open-label, extension study to evaluate the safety and efficacy of combinat...
Show More Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Switching Undetectables to Selzentry PHASE4 This pilot single arm, single site, open-labeled switch study seeks to enro...
Show More Location
St. Hope Foundation, Inc.
Learn More & Join Trial